AirDuo™ RespiClick® (fluticasone/salmeterol) – New drug and first-time generic launch
April 20, 2017 – Teva announced the simultaneous launch of AirDuo RespiClick (fluticasone/ salmeterol) and its authorized generic for the treatment of asthma in patients aged 12 years and older.
Download PDF
